Hostname: page-component-68945f75b7-72kh6 Total loading time: 0 Render date: 2024-08-05T11:22:26.494Z Has data issue: false hasContentIssue false
  • English
  • Français

Gene Therapy and AIDS: A Constitutional Politics Report

Published online by Cambridge University Press:  17 May 2016

Ira H. Carmen
Ira H. Carmen*
Affiliation:
University of Illinois, USA
*
Department of Political Science, 361 Lincoln Hall, 702 S. Wright St., University of Illinois, Urbana, IL 61801, USA.
Get access

Extract

On May 11, 1993, the National Academy of Sciences hosted a workshop convened to address the scientific, medical, and social issues arising from attempts to enlist gene therapy experimentation in the fight against AIDS. The 100 participants represented a cross-section of federal governmental, industrial, academic, and research-practitioner expertise. I was invited presumably because I am a member of the Recombinant DNA Advisory Committee (RAC), an arm of the National Institutes of Health, which oversees (in effect, licenses) human gene therapy protocols, and because I have recently published reports bearing on that policy process (Carmen, 1992, 1993).

Type
CONFERENCE REPORT
Information
Politics and the Life Sciences , Volume 12 , Issue 2 , August 1993 , pp. 279 - 280
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carmen, I.H. (1992). “Debates, Divisions, and Decisions: Recombinant DNA Advisory Committee (RAC) Authorization of the First Human Gene Transfer Experiments.” American Journal of Human Genetics 50:245–60.Google Scholar
Carmen, I.H. (1993). “Human Gene Therapy: A Biopolitical Overview and Analysis.” Human Gene Therapy 4:187–93.CrossRefGoogle Scholar